A Pilot Trial of Clazakizumab in Late ABMR

Clinical trial NCT03444103 · COMPLETED

Trial details

NCT number: NCT03444103
Sponsor: Medical University of Vienna
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Antibody-mediated Rejection

Start date: 2018-01-16
Primary completion: 2020-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.